Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice

BACKGROUND: The safety and efficacy of olmesartan 40 mg and hydrochlorothiazide (HCTZ) as a fixed-dose combination has been investigated in clinical trials leading to its approval. The aims of the present study were to confirm these data in an unselected patient population in daily practice and to d...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Bramlage, Peter, Zemmrich, Claudia, Ketelhut, Reinhard, Wolf, Wolf-Peter, Fronk, Eva-Maria, Schmieder, Roland E
التنسيق: Artigo
اللغة:Inglês
منشور في: Dove Medical Press 2013
الموضوعات:
Original Research
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC3769201/
https://ncbi.nlm.nih.gov/pubmed/24039432
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/VHRM.S49118
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة